Novel Model of Antigen-Specific Induction of Bile Duct Injury

Gastroenterology

Volumn 131, Issue 6, 2006, Pages 1899-1906

  Buxbaum, James ^a   Qian, Peiqing ^b   Khuu, Ciera ^a   Shneider, Benjamin L ^c   Daikh, David I ^a   Gershwin, M Eric ^d   Allen, Paul M ^b   Peters, Marion G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BILE DUCT INJURY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS; LIVER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 33845652316     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.10.020     Document Type: Article

References (34)

1. Bertolino P., Klimpel G., and Lemon S.M. Hepatic inflammation and immunity: a summary of a conference on the function of the immune system within the liver. Hepatology 31 (2000) 1374-1378
2. Kita H., Mackay I.R., Van De W.J., and Gershwin M.E. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120 (2001) 1485-1501
3. Doherty D.G., Norris S., Madrigal-Estebas L., McEntee G., Traynor O., Hegarty J.E., and O'Farrelly C. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 163 (1999) 2314-2321
4. Ludwig J., Batts K.P., and MacCarty R.L. Ischemic cholangitis in hepatic allografts. Mayo Clin Proc 67 (1992) 519-526
5. Yusuf T.E., and Baron T.H. AIDS cholangiopathy. Curr Treat Options Gastroenterology 7 (2004) 111-117
6. Gregorio G.V., Portmann B., Karani J., Harrison P., Donaldson P.T., Vergani D., and Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33 (2001) 544-553
7. Chen F., Ma L., Al Ansari N., and Shneider B. The role of AP-1 in the transcriptional regulation of the rat apical sodium-dependent bile acid transporter. J Biol Chem 276 (2001) 38703-38714
8. Kurts C., Carbone F.R., Barnden M., Blanas E., Allison J., Heath W.R., and Miller J.F. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 186 (1997) 2057-2062
9. Batts K.P., and Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409-1417
10. Daikh D.I., and Wofsy D. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J Immunol 166 (2001) 2913-2916
11. Nishio A., van de Water J., Leung P.S., Joplin R., Neuberger J.M., Lake J., Bjorkland A., Totterman T.H., Peters M., Worman H.J., Ansari A.A., Coppel R.L., and Gershwin M.E. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 25 (1997) 1085-1089
12. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., and Van Kaer L. NKT cells: what's in a name?. Nat Rev Immunol 4 (2004) 231-237
13. Baron J.L., Gardiner L., Nishimura S., Shinkai K., Locksley R., and Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16 (2002) 583-594
14. Ichiki Y., Aoki C.A., Bowlus C.L., Shimoda S., Ishibashi H., and Gershwin M.E. T-cell immunity in autoimmune hepatitis. Autoimmun Rev 4 (2005) 315-321
15. Anderson M.S., and Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23 (2005) 447-485
16. Bumgardner G.L., Li J., Prologo J.D., Heininger M., and Orosz C.G. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection. Transplantation 68 (1999) 555-562
17. Bowen D.G., Warren A., Davis T., Hoffmann M.W., McCaughan G.W., de St Groth B.F., and Bertolino P. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology 123 (2002) 1252-1264
18. Vanderlugt C.L., Begolka W.S., Neville K.L., Katz-Levy Y., Howard L.M., Eagar T.N., Bluestone J.A., and Miller S.D. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 164 (1998) 63-72
19. Mehal W.Z., Azzaroli F., and Crispe I.N. Antigen presentation by liver cells controls intrahepatic T-cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T-cell apoptosis. J Immunol 167 (2001) 667-673
20. Crispe I.N., Dao T., Klugewitz K., Mehal W.Z., and Metz D.P. The liver as a site of T-cell apoptosis: graveyard, or killing field?. Immunol Rev 174 (2000) 47-62
21. Kita H., Lian Z.X., Van De W.J., He X.S., Matsumura S., Kaplan M., Luketic V., Coppel R.L., Ansari A.A., and Gershwin M.E. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T-cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 195 (2002) 113-123
22. Tanaka A., Iwabuchi S., Takatori M., Ohno A., Yamada H., Hashimoto N., Ikeda Y., Kato T., Nishioka K., Iino S., and Yamamoto K. Clonotypic analysis of T cells in patients with autoimmune and viral hepatitis. Hepatology 25 (1997) 1070-1076
23. Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M.J., and Godfrey D.I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171 (2003) 4020-4027
24. Vierling J.M. Animal models for primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 15 (2001) 591-610
25. Tsuneyama K., Nose M., Nisihara M., Katayanagi K., Harada K., and Nakanuma Y. Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL/lpr mice: possible animal model for primary biliary cirrhosis. Pathol Int 51 (2001) 418-424
26. Tsuneyama K., Kono N., Hoso M., Sugahara H., Yoshida K., Katayanagi K., Gershwin M.E., Saito K., and Nakanuma Y. aly/aly Mice: a unique model of biliary disease. Hepatology 27 (1998) 1499-1507
27. Mauad T.H., van Nieuwkerk C.M., Dingemans K.P., Smit J.J., Schinkel A.H., Notenboom R.G., van den Bergh Weerman M.A., Verkruisen R.P., Groen A.K., and Oude Elferink R.P. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 145 (1994) 1237-1245
28. Howell C.D., Yoder T., Claman H.N., and Vierling J.M. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease. J Immunol 143 (1989) 476-483
29. Li J., Helm K., and Howell C.D. Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease. Transplantation 62 (1996) 1621-1628
30. Nonomura A., Kono N., Minato H., and Nakanuma Y. Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft-versus-host disease in mice. Pathol Int 48 (1998) 421-427
31. Krams S.M., Dorshkind K., and Gershwin M.E. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 170 (1989) 1919-1930
32. Kobashi H., Yamamoto K., Yoshioka T., Tomita M., and Tsuji T. Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis. Hepatology 19 (1994) 1424-1430
33. Iqbal N., Oliver J.R., Wagner F.H., Lazenby A.S., Elson C.O., and Weaver C.T. T-helper 1 and T-helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 195 (2002) 71-84
34. Ehst B.D., Ingulli E., and Jenkins M.K. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant 3 (2003) 1355-1362